1. Home
  2. PXLW vs PLUR Comparison

PXLW vs PLUR Comparison

Compare PXLW & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

N/A

Current Price

$6.01

Market Cap

39.1M

Sector

Technology

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$3.38

Market Cap

33.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PXLW
PLUR
Founded
1997
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
33.9M
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
PXLW
PLUR
Price
$6.01
$3.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$14.33
$12.00
AVG Volume (30 Days)
23.9K
6.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.78
EPS
N/A
N/A
Revenue
$43,206,000.00
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
$3.54
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
309.82
52 Week Low
$0.46
$2.82
52 Week High
$15.42
$7.13

Technical Indicators

Market Signals
Indicator
PXLW
PLUR
Relative Strength Index (RSI) 45.89 44.88
Support Level $5.67 $3.13
Resistance Level $6.77 $3.42
Average True Range (ATR) 0.30 0.17
MACD 0.02 -0.05
Stochastic Oscillator 34.46 18.95

Price Performance

Historical Comparison
PXLW
PLUR

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: